Saturday, May 18, 2024
HomeTagsPreclinical Proof

Preclinical Proof

Avenge Bio Announces Peer-Reviewed Publication on Preclinical Proof of Concept for LOCOcyte™ Platform Technology

Avenge Bio, Inc., ("Avenge" or the "Company") a biotechnology company developing the LOCOcyte™ immunotherapy platform for the precision administration of potent immune effector molecules...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics